A New Research From Ludwig Cancer Research
A Ludwig Cancer Research research has devised a different type of chimeric antigen receptor (CAR) T cell—a family of promising immunotherapies for cancer—that might be…
A Ludwig Cancer Research research has devised a different type of chimeric antigen receptor (CAR) T cell—a family of promising immunotherapies for cancer—that might be…
A new drug application (NDA) has been registered for expedited approval with the FDA for lurbinectedin in sufferers with small-cell lung cancer (SCLC) who have…